Increasing evidence demonstrates that NPTX2 acts as either an oncogene or tumor suppressor in different tumor types, being significantly upregulated in colorectal cancer (CRC) 14 and frequently downregulated in pancreatic cancer 15 compared to control tissue. The gene discussed is NPTX2; the disease is neoplasm.